Glenmark Pharmaceuticals has informed that the Board of Directors of the Company, at its Meeting held on July 24, 2014 allotted 24,100 equity shares to the employees of the Company on exercise of options granted to them pursuant to ESOS 2003.
The above information is a part of company’s filings submitted to BSE